Gasami Therapeutics, Inc. — Form D

Gasami Therapeutics, Inc. of RICHMOND, VA, a company, filed a Form D exempt-offering notice with the SEC on 2026-01-12. The offering totals $250K, of which $20K was reported sold. Industry: Biotechnology.

Offering

• Filed: 2026-01-12
• Form: D
• Accession: 0002104347-26-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $250K
• Amount sold: $20K
• Remaining: $230K
• Investors: 1
• Date of first sale: 2025-12-04
• Security types: debt
• Revenue range: No Revenues
• SEC file number: 021-569660

Issuer

• Name: Gasami Therapeutics, Inc.
• CIK: 0002104347
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2025
• Address: 8401 MAYLAND DR, RICHMOND, VA, 23294
• Phone: 4342821615

Officers, directors & promoters (1)

More

• CIK 2104347 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search